fluconazole has been researched along with Neurodegenerative Diseases in 1 studies
Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.
Neurodegenerative Diseases: Hereditary and sporadic conditions which are characterized by progressive nervous system dysfunction. These disorders are often associated with atrophy of the affected central or peripheral nervous system structures.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Fluconazole was able to prevent neurite retraction and cell death in in vitro and in vivo models of toxicity." | 1.72 | Fluconazole Is Neuroprotective via Interactions with the IGF-1 Receptor. ( Bachani, M; Johnson, TP; Lee, MH; Malik, N; Nath, A; Ruffin, A; Steiner, JP; Toodle, V; Vivekanandhan, S; Wang, T, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Toodle, V | 1 |
| Lee, MH | 1 |
| Bachani, M | 1 |
| Ruffin, A | 1 |
| Vivekanandhan, S | 1 |
| Malik, N | 1 |
| Wang, T | 1 |
| Johnson, TP | 1 |
| Nath, A | 1 |
| Steiner, JP | 1 |
1 other study available for fluconazole and Neurodegenerative Diseases
| Article | Year |
|---|---|
Fluconazole Is Neuroprotective via Interactions with the IGF-1 Receptor.
Topics: Animals; Antifungal Agents; D-Aspartic Acid; Fluconazole; Insulins; Neurodegenerative Diseases; Neur | 2022 |